On Friday shares of GenVec, Inc. (NASDAQ:GNVC) closed at $2.39. Company’s sales growth for last 5 years was -15.50% and EPS growth for next 5 years is recorded as 35.00%. GenVec, Inc. (NASDAQ: GNVC) announced on 14 May, that Douglas E. Brough, the company’s chief scientific officer, gave a presentation entitled “Gorilla Adenovirus Vectors for Molecular Therapeutics and Vaccines” at the 18th Annual Meeting of the American Society of Gene & Cell Therapy.
Novavax, Inc. (NASDAQ:NVAX) in last trading activity fell -1.04% to close at $8.54. Company weekly performance is 3.77% while its quarterly performance stands at -2.95%. Novavax, Inc. (NASDAQ:NVAX) is -14.17% away from its 52 week high. Novavax, Inc. (NASDAQ:NVAX) on May 07, 2015, declared its financial results for the first quarter 2015. Novavax reported a net loss of $24.4 million, or $0.10 per share, for the first quarter of 2015, compared to a net loss of $13.8 million, or $0.07 per share, for the first quarter of 2014. Novavax revenue in the first quarter of 2015 increased 32% to $9.9 million, compared to $7.5 million for the same period in 2014.
On last trading day Sony Corp (ADR) (NYSE:SNE) increased 1.71% to close at $32.74. Its volatility for the week is 1.19% while volatility for the month is 1.44%. SNE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was -4.80%. Sony Corp (ADR) (NYSE:SNE) monthly performance is 5.34%. Sony Corp. (ADR) (NYSE:SNE) President Kazuo Hirai and seven other corporate executive officers will give up their bonuses for the fourth consecutive year to take responsibility for the company’s massive loss for fiscal 2014, company sources said Thursday.
Tesla Motors Inc (NASDAQ:TSLA) has 0.10% insider ownership while its institutional ownership stands at 63.80%. In last trading activity company’s stock closed at $248.84. Tesla Motors Inc (NASDAQ:TSLA) is preparing to introduce an autopilot feature this year for the luxury electric cars built at its Fremont factory, while Mercedes-Benz has leased a former naval weapons depot in Concord to serve as a giant test track for its own self-driving cars.
On last trading day BioMed Realty Trust Inc. (NYSE:BMR) increased 1.73% to close at $21.12. Its volatility for the week is 2.44% while volatility for the month is 1.91%. BMR’s sales growth for past 5 years was 13.30% and its EPS growth for past 5 years was 16.80%. BioMed Realty Trust Inc. (NYSE:BMR) monthly performance is -0.47%. BioMed Realty Trust (NYSE: BMR), which owns the three buildings at 200 Sidney St., 40 Erie St. and 21 Erie St. as well as an adjacent parking garage, is rebranding the area as Sidney Research Campus. Bill Kane, BioMed’s vice president of leasing and development focused on the Cambridge area, said on 14 May, his firm has done “exhaustive research” and found the biggest need in the life sciences right now is from smaller companies being pushed out of Kendall Square.